| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $291K | +32.8% |
| Cost of Revenue | $77K | -35.7% |
| Gross Profit | $213K | +116.4% |
| R&D Expense | $1.0M | — |
| SG&A Expense | $370K | +21.4% |
| Net Income | -$5.5M | -147.1% |
| EPS (Basic) | -$0.02 | -100.0% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2K | -93.4% |
| Accounts Receivable | $207K | +439.8% |
| Inventory | $24K | — |
| Current Assets | $236K | -4.3% |
| Total Assets | $2.4M | +9.3% |
| Current Liabilities | $5.6M | +29.9% |
| Total Liabilities | $7.6M | +35.8% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.2M | -34.2% |
| Capital Expenditures | $269K | -30.4% |
| Investing Cash Flow | -$269K | +87.7% |
| Financing Cash Flow | $2.4M | -37.1% |
| Free Cash Flow | -$2.4M | -21.7% |
| Stockholders' Equity |
| -$5.2M |
| -52.6% |